147 related articles for article (PubMed ID: 9366513)
1. The effects of repeated morphine exposure on mu opioid receptor number and affinity in C57BL/6J and DBA/2J mice.
Petruzzi R; Ferraro TN; Kürschner VC; Golden GT; Berrettini WH
Life Sci; 1997; 61(20):2057-64. PubMed ID: 9366513
[TBL] [Abstract][Full Text] [Related]
2. Solubilization of high-affinity, guanine nucleotide-sensitive mu-opioid receptors from rat brain membranes.
Weems HB; Chalecka-Franaszek E; Côté TE
J Neurochem; 1996 Mar; 66(3):1042-50. PubMed ID: 8769865
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of mu and delta opioid binding sites in striatal slices of morphine-tolerant and -dependent mice.
Abdelhamid EE; Takemori AE
Eur J Pharmacol; 1991 Jun; 198(2-3):157-63. PubMed ID: 1650700
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of brain and spinal cord mu-opiate receptors in morphine tolerant-dependent rats.
Bhargava HN; Gulati A
Eur J Pharmacol; 1990 Nov; 190(3):305-11. PubMed ID: 2176984
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of mu-opioid binding sites following chronic administration of neuropeptide FF (NPFF) and morphine.
Goodman CB; Emilien B; Becketts K; Cadet JL; Rothman RB
Peptides; 1996; 17(3):389-97. PubMed ID: 8735964
[TBL] [Abstract][Full Text] [Related]
6. Opiate withdrawal intensity correlates with the presence of DSLET high-affinity binding.
Yukhananov RYu ; Klodt PM; Il'Ina AD; Zaitsev SV; Maisky AI
Pharmacol Biochem Behav; 1994 Dec; 49(4):1109-12. PubMed ID: 7886084
[TBL] [Abstract][Full Text] [Related]
7. Effects of intracerebroventricular beta-funaltrexamine on mu and delta opioid receptors in the rat: dichotomy between binding and antinociception.
Liu-Chen LY; Li SX; Wheeler-Aceto H; Cowan A
Eur J Pharmacol; 1991 Oct; 203(2):195-202. PubMed ID: 1666046
[TBL] [Abstract][Full Text] [Related]
8. Chronic exposure to morphine and naltrexone induces changes in catecholaminergic neurotransmission in rat brain without altering mu-opioid receptor sensitivity.
De Vries TJ; Tjon Tien Ril GH; Van der Laan JW; Mulder AH; Schoffelmeer AN
Life Sci; 1993; 52(21):1685-93. PubMed ID: 8388977
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of morphine tolerance and dependence by diazepam and its relation to mu-opioid receptors in the rat brain and spinal cord.
Tejwani GA; Sheu MJ; Sribanditmongkol P; Satyapriya A
Brain Res; 1998 Jun; 797(2):305-12. PubMed ID: 9666154
[TBL] [Abstract][Full Text] [Related]
10. Prenatal exposure to morphine alters brain mu opioid receptor characteristics in rats.
Rimanóczy A; Vathy I
Brain Res; 1995 Sep; 690(2):245-8. PubMed ID: 8535844
[TBL] [Abstract][Full Text] [Related]
11. Absence of G-protein activation by mu-opioid receptor agonists in the spinal cord of mu-opioid receptor knockout mice.
Narita M; Mizoguchi H; Narita M; Sora I; Uhl GR; Tseng LF
Br J Pharmacol; 1999 Jan; 126(2):451-6. PubMed ID: 10077238
[TBL] [Abstract][Full Text] [Related]
12. Effects of NMDA receptor antagonists on inhibition of morphine tolerance in rats: binding at mu-opioid receptors.
Wong CS; Cherng CH; Luk HN; Ho ST; Tung CS
Eur J Pharmacol; 1996 Feb; 297(1-2):27-33. PubMed ID: 8851162
[TBL] [Abstract][Full Text] [Related]
13. Opioid agonist and antagonist treatment differentially regulates immunoreactive mu-opioid receptors and dynamin-2 in vivo.
Yoburn BC; Purohit V; Patel K; Zhang Q
Eur J Pharmacol; 2004 Sep; 498(1-3):87-96. PubMed ID: 15363980
[TBL] [Abstract][Full Text] [Related]
14. C57BL/6J-bgJ (beige) mice: differential sensitivity in the tail flick test to centrally administered mu- and delta-opioid receptor agonists.
Mathiasen JR; Raffa RB; Vaught JL
Life Sci; 1987 May; 40(20):1989-94. PubMed ID: 3033418
[TBL] [Abstract][Full Text] [Related]
15. Effect of intracerebroventricular beta-funaltrexamine on mu opioid receptors in the rat brain: consideration of binding condition.
Liu-Chen LY; Yang HH; Li S; Adams JU
J Pharmacol Exp Ther; 1995 Jun; 273(3):1047-56. PubMed ID: 7791074
[TBL] [Abstract][Full Text] [Related]
16. Effects of prenatal morphine and adult estrogen administration on mu-opioid inhibition of norepinephrine release from hypothalamic slices.
Vathy I; Etgen AM
Neuroendocrinology; 1996 Jan; 63(1):61-8. PubMed ID: 8839356
[TBL] [Abstract][Full Text] [Related]
17. [Heterogeneity of mu- and delta-opioid active sites in the mouse cerebral cortex. Selective increase in the affinity of a superhigh affinity delta-site during long-term administration of morphine].
Zaĭtsev SV; Il'ina AD; Klodt PM; Varfolomeev SD; Iukhananov RIu
Biokhimiia; 1992 Aug; 57(8):1242-7. PubMed ID: 1327189
[TBL] [Abstract][Full Text] [Related]
18. Binding in vivo of selective mu and delta opioid receptor agonists: opioid receptor occupancy by endogenous enkephalins.
Meucci E; Delay-Goyet P; Roques BP; Zajac JM
Eur J Pharmacol; 1989 Nov; 171(2-3):167-78. PubMed ID: 2559856
[TBL] [Abstract][Full Text] [Related]
19. Role of cAMP-dependent protein kinase (PKA) in opioid agonist-induced mu-opioid receptor downregulation and tolerance in mice.
Shen J; Benedict Gomes A; Gallagher A; Stafford K; Yoburn BC
Synapse; 2000 Dec; 38(3):322-7. PubMed ID: 11020235
[TBL] [Abstract][Full Text] [Related]
20. Endogenous opioids released by suspending mice by the tail selectively enhance spinal mu opioid analgesia.
Smith FL; Brase DA; Dombrowski DS; Dewey WL
J Pharmacol Exp Ther; 1994 Sep; 270(3):1177-85. PubMed ID: 7932169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
